Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

Published Jul 17, 2020

Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

A new option for the treatment of metastatic colorectal cancer, immune checkpoint inhibitor Keytruda, has been approved by the FDA -- marking historic progress for certain patients

NOW
PLAYING
Ovarian Cancer Recent PARP Inhibitor Approvals
NOW
PLAYING
Some Cancer Patients Can Get Chemotherapy Without A Higher Risk Of COVID-19 Infection, Study Shows
NOW
PLAYING
Ovarian Cancer Treatment Decisions
NOW
PLAYING
Baltimore Orioles Outfielder, Trey Mancinci's Stage 3 Colon Cancer Fight Inspired By His Dad
NOW
PLAYING
HIPEC to Treat Ovarian Cancer, and Who Is Eligible
NOW
PLAYING
New Hope For Esophageal Cancer Patients -- Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer

Treatment: Making Wise Surgery Decisions

SEE MORE   

Treatment: Making Wise Surgery Decisions

There is plenty of marketing information out there about the best surgery techniques, and the best places to have your operation done. Doing your own research is crucial before committing to any treatment.

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.